Skip to content
lifestyle.bossesmag.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
OKYO Pharma LTD
OKYO Expands Scientific Advisory Board with the Appointment of International Expert Marta Sacchetti, MD, PhD
May 30, 2026
OKYO CEO and CSO to Present and Leadership Team to Participate at Upcoming Scientific Conferences in May
May 27, 2026
OKYO Pharma Announces Scientific Advisory Board Meeting and Urcosimod Data Presentation During ASCRS Annual Meeting
May 24, 2026
OKYO Pharma Announces Chairman and Founder Acquires Shares
May 21, 2026
OKYO Pharma Announces Director Acquires Shares
May 20, 2026
OKYO Pharma Announces Chief Development Officer and Director Acquires Shares
May 20, 2026
OKYO Pharma Reports New Phase 2 Data Demonstrating Meaningful Improvements in Patient-Reported Quality of Life Outcomes with Urcosimod in Neuropathic Corneal Pain
May 20, 2026
OKYO Pharma Announces Acceptance of Urcosimod Phase 2 Study Results for Presentation at Prestigious ASCRS Annual Meeting
January 30, 2026
OKYO Pharma Announces Successful Type C Meeting with the FDA
January 28, 2026
FDA Approves Compassionate Use of Urcosimod (0.05%) for the Treatment of Neuropathic Corneal Pain
January 23, 2026